Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA
Open Access
- 1 May 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (5) , 942-946
- https://doi.org/10.1038/mt.2008.51
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticlesJournal of Controlled Release, 2008
- Tumor-targeted Delivery of siRNA by Self-assembled NanoparticlesMolecular Therapy, 2008
- Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cellsNucleic Acids Research, 2007
- Preparation and Biologic Evaluation of a Novel Radioiodinated Benzylpiperazine, 123I-MEL037, for Malignant MelanomaJournal of Nuclear Medicine, 2007
- Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISCNucleic Acids Research, 2007
- Polyethylenimine-complexed Plasmid Particles Targeting Focal Adhesion Kinase Function as Melanoma Tumor TherapeuticsMolecular Therapy, 2007
- Future Directions in Vascular Endothelial Growth Factor–Targeted Therapy for Metastatic Colorectal CancerSeminars in Oncology, 2006
- Targeting c-Myc, Ras and IGF Cascade to Treat Cancer and Vascular DisordersCell Cycle, 2006
- Tumor Growth Inhibition by Simultaneously Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 in a Xenograft ModelClinical Cancer Research, 2005
- Anisamide‐targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cellsInternational Journal of Cancer, 2004